Malignant mixed Mullerian tumor

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Malignant Mixed Mesodermal Tumor (MMMT) – Early Stage With Postoperative XRT/Chemotherapy
Status:
Terminated
Last Changed:
Sep 15, 2011
First Changed:
Jul 23, 2007
Disease(s):
Uterine Neoplasms
Intervention(s):
CarboplatinCisplatinPaclitaxel
Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Status:
Terminated
Last Changed:
Aug 7, 2013
First Changed:
Jun 28, 2011
Disease(s):
Cholestasis, Progressive Familial Intrahepatic 3
Intervention(s):
Yttrium microsphere injection
A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma
Status:
Unknown status
Last Changed:
Oct 19, 2011
First Changed:
Oct 19, 2011
Disease(s):
Recurrent Endometrial Cancer
Intervention(s):
Lapatinib and ixempra

Connect. Empower. Inspire.